Noah L. Rosenberg

Noah L.
Rosenberg worked as an Executive Director & Head-Cardiovascular at Forest Research Institute, Inc. from 2009 to 2012.
He then served as the Chief Medical Officer at Esperion Therapeutics, Inc. from 2012 to 2014, followed by the same position at Medimetriks Pharmaceuticals, Inc. from 2014 to 2018, and at Travere Therapeutics, Inc. from 2018 to 2021.
Rosenberg received his undergraduate degree from The Johns Hopkins University in 1989 and his doctorate from Drexel University College of Medicine in 1993.